Logo

Genaissance, Bayer Partner in Search for Genomic Markers

Jan 21, 2003

NEW YORK, Jan. 21 - Genaissance Pharmaceuticals and Bayer Diagnostics said today they are collaborating on finding pharmacogenomics markers for drug safety and efficacy.

 

In the partnership, Genaissance will use its HAP technology to analyze clinical samples provided by the diagnostics division of Bayer HealthCare.

 

Terms of the deal call for Genaissance to receive royalties and rights to perform diagnostic tests developed and marketed by Bayer, according to the companies.

 

Financial details of the agreement were not disclosed.

 

Click here for more information.

 

 

Breaking News
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.